Cargando…
Identifying Meibomian Gland Dysfunction Biomarkers in a Cohort of Patients Affected by DM Type II
(1) Background: Meibomian gland dysfunction (MGD) among patients with diabetes mellitus (DM) is a common manifestation of dry eye syndrome (DES). (2) Methods: The purpose of this study is to identify clinical parameters and biomarkers useful to improve the follow-up and the treatment of these patien...
Autores principales: | Abbouda, Alessandro, Florido, Antonio, Avogaro, Filippo, Bladen, John, Vingolo, Enzo Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123711/ https://www.ncbi.nlm.nih.gov/pubmed/37092461 http://dx.doi.org/10.3390/vision7020028 |
Ejemplares similares
-
Update on Gene Therapy Clinical Trials for Choroideremia and Potential Experimental Therapies
por: Abbouda, Alessandro, et al.
Publicado: (2021) -
Gene Therapy in Hereditary Retinal Dystrophies: The Usefulness of Diagnostic Tools in Candidate Patient Selections
por: Malvasi, Mariaelena, et al.
Publicado: (2023) -
Growth of meibomian gland tissue after intraductal meibomian gland probing in patients with obstructive meibomian gland dysfunction
por: Maskin, Steven L, et al.
Publicado: (2018) -
A Novel Quantitative Index of Meibomian Gland Dysfunction, the Meibomian Gland Tortuosity
por: Lin, Xiaolei, et al.
Publicado: (2020) -
Uneven Meibomian Gland Dropout in Patients with Meibomian Gland Dysfunction and Demodex Infestation
por: Yu, Xinxin, et al.
Publicado: (2022)